Carmustine and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 60+ old, also take Etoposide, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Cellulitis when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,145 drugs and 2,328 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Aug, 21, 2025

4,562 people reported to have side effects when taking Carmustine.
Among them, 22 people (0.48%) have Cellulitis.

Among these 22 people:

What is the gender of people who have Cellulitis when taking Carmustine? *

female: 26.32 %
male: 73.68 %

What is the age of people who have Cellulitis when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Cellulitis? *

Death: 15 people, 68.18%
Cardiac Tamponade (fluid accumulates in heart covering): 10 people, 45.45%
Tumor Lysis Syndrome: 10 people, 45.45%
Drug Ineffective: 10 people, 45.45%
Myelosuppression (a decrease in the production of blood cells): 10 people, 45.45%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 40.91%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 40.91%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 9 people, 40.91%
Hepatic Lesion: 8 people, 36.36%
Splenic Lesion (lesion on spleen): 8 people, 36.36%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 13 people, 59.09%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 12 people, 54.55%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 10 people, 45.45%
Fever: 9 people, 40.91%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 9 people, 40.91%
Lymphoma (cancer that begins in immune system cells): 3 people, 13.64%
Haematopoietic Stem Cell Mobilisation: 2 people, 9.09%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 4.55%
Renal Amyloidosis (deposit of amyloid in kidney): 1 person, 4.55%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Cellulitis treatments and more:

Cellulitis (75,289 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,145 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,328 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.